Treatment Action Group

TAG's 2020 Pipeline Report: TB chapters released

Treatment Action Group (TAG) launches newly available TB chapters of its 2020 Pipeline Report.

Read More →

A higher standard of TB care webinar materials now available online

On September 2nd and 3rd, Treatment Action Group (TAG) held a webinar series, “Demanding a Higher Standard of TB Care: New Tools, New Challenges, New Approaches to Improving TB Diagnosis and Treatment,” officially launching the two latest additions to TAG’s series of materials designed for community leaders, An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis and An Activist’s Guide to Tuberculosis Diagnostic Tools.

Read More →

TAG policy brief: Advancing Access through Market Interventions

Lessons Learned from the GeneXpert Tuberculosis Test Buy-Down

Read More →

Public investment in bedaquiline up to five-fold that of Johnson & Johnson

PLOS ONE publishes TAG’s rigorous, peer-reviewed calculation of investments in the development of this life-saving TB medicine.

Read More →

TAG policy brief: TB Research Investments Provide Returns in Combating Both TB and COVID-19

Sustained and expanded financing is needed to safeguard TB research against COVID-19–related disruptions and improve global epidemic preparedness.

Read More →

Letter to Sanofi calling for patent withdrawals on critical TB drugs

TAG and OTMeds call on Sanofi to reverse its efforts to patent two obvious combinations of two critical drugs to prevent TB: rifapentine and isoniazid.

Read More →

TAG launches two new TB Activist Guides

Treatment Action Group launches two new TB Activist Guides: An Activist’s Guide to Tuberculosis Diagnostic Tools, and An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis.

Read More →

Treatment Action Group statement on bedaquiline unaffordability

Bedaquiline is a public good, and must be treated as such. Johnson & Johnson once again refused to meet evidence-based demands to price bedaquiline at $1/day.

Read More →

TAGline May 2020: Realizing the Right to Science

Treatment Action Group released the May 2020 edition of TAGline, focused on the right to science.

Read More →

Global health and human rights organizations denounce Trump Administration decision to pull commitments to WHO during COVID-19 crisis

Cutting global health funding in the middle of a pandemic will only prolong the devastating loss of life and economic damage in the U.S. and across the world, and undermine the response to other infectious diseases, including HIV, TB, and hepatitis C.

Read More →

Page 1 of 16 · Total posts: 10

1 2 Last→